Internationally recognized expert brings over 30 years of experience in the field of cardiovascular disease TOULOUSE, France and ANN ARBOR, USA, 22 November 2011. Cerenis Therapeutics, a …
Cerenis Appoints John F. Paolini as Chief Medical Officer
Internationally recognized expert brings over 15 years of experience in drug development and commercialisation to treat cardiovascular disease Toulouse (France) and Ann Arbor (United States), 22 …
Cerenis Initiates Phase 2 Study of Lead Product Candidate, CER-001, in Patients with Acute Coronary Syndrome
TOULOUSE, France and ANN ARBOR, Michigan, March 15, 2011. Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and …